FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]
Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3764190013 | Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial lyophilized powder for conventional release suspension for injection (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3764191012 | Triptorelin (as triptorelin pamoate) 22.5 mg lyophilized powder for suspension for injection vial | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3786509018 | Triptorelin (as triptorelin pamoate) 22.5 mg lyophilised powder for suspension for injection vial | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 2869168010 | Triptorelin pamoate 22.5mg lyophilized powder for injection suspension (product) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 2869168010 | Triptorelin pamoate 22.5mg lyophilized powder for injection suspension (product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 2871537019 | Triptorelin pamoate 22.5mg lyophilised powder for injection suspension | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 2871537019 | Triptorelin pamoate 22.5mg lyophilised powder for injection suspension | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 2872013013 | Triptorelin pamoate 22.5mg lyophilized powder for injection suspension | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 2872013013 | Triptorelin pamoate 22.5mg lyophilized powder for injection suspension | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3764190013 | Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial lyophilized powder for conventional release suspension for injection (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3764191012 | Triptorelin (as triptorelin pamoate) 22.5 mg lyophilized powder for suspension for injection vial | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3786509018 | Triptorelin (as triptorelin pamoate) 22.5 mg lyophilised powder for suspension for injection vial | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial lyophilized powder for conventional release suspension for injection (clinical drug) | Is a | Product manufactured as parenteral dose form | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial lyophilized powder for conventional release suspension for injection (clinical drug) | Is a | Product containing triptorelin (medicinal product) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial lyophilized powder for conventional release suspension for injection (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Triptorelin pamoate (substance) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial lyophilized powder for conventional release suspension for injection (clinical drug) | Has manufactured dose form | Lyophilized powder for conventional release suspension for injection | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial lyophilized powder for conventional release suspension for injection (clinical drug) | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial lyophilized powder for conventional release suspension for injection (clinical drug) | Has presentation strength numerator value | 22.5 | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
| Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial lyophilized powder for conventional release suspension for injection (clinical drug) | Has presentation strength numerator unit (attribute) | mg | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
| Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial lyophilized powder for conventional release suspension for injection (clinical drug) | Has unit of presentation | Vial (unit of presentation) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial lyophilized powder for conventional release suspension for injection (clinical drug) | Is a | Triptorelin only product in parenteral dose form | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial lyophilized powder for conventional release suspension for injection (clinical drug) | Has basis of strength substance (attribute) | Triptorelin (substance) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
| Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial lyophilized powder for conventional release suspension for injection (clinical drug) | Count of base of active ingredient | un | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial lyophilized powder for conventional release suspension for injection (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
| Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial lyophilized powder for conventional release suspension for injection (clinical drug) | Has presentation strength denominator unit (attribute) | Vial (unit of presentation) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
| Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial lyophilized powder for conventional release suspension for injection (clinical drug) | Has precise active ingredient | Triptorelin pamoate (substance) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
| Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial lyophilized powder for conventional release suspension for injection (clinical drug) | Plays role | Antineoplastic therapeutic role | false | Inferred relationship | Existential restriction modifier (core metadata concept) |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator attribute value reference set (foundation metadata concept)
REPLACED BY association reference set (foundation metadata concept)